160 related articles for article (PubMed ID: 18205861)
1. Stem cell transplantation for children with Glanzmann thrombasthenia.
Connor P; Khair K; Liesner R; Amrolia P; Veys P; Ancliff P; Mathias M
Br J Haematol; 2008 Mar; 140(5):568-71. PubMed ID: 18205861
[TBL] [Abstract][Full Text] [Related]
2. Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia.
Flood VH; Johnson FL; Boshkov LK; Thomas GA; Nugent DJ; Bakke AC; Nicholson HS; Tilford D; Brown MP; Godder KT
Pediatr Blood Cancer; 2005 Dec; 45(7):971-5. PubMed ID: 15768382
[TBL] [Abstract][Full Text] [Related]
3. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning.
Steiner M; Matthes-Martin S; Attarbaschi A; Minkov M; Grois N; Unger E; Holter W; Vormoor J; Wawer A; Ouachee M; Woessmann W; Gadner H
Bone Marrow Transplant; 2005 Aug; 36(3):215-25. PubMed ID: 15937510
[TBL] [Abstract][Full Text] [Related]
4. Sustained engraftment and resolution of bleeding phenotype after unrelated cord blood hematopoietic stem cell transplantation for severe glanzmann thrombasthenia.
Miller W; Dunn A; Chiang KY
J Pediatr Hematol Oncol; 2009 Jun; 31(6):437-9. PubMed ID: 19648793
[TBL] [Abstract][Full Text] [Related]
5. Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases.
Satwani P; Cooper N; Rao K; Veys P; Amrolia P
Bone Marrow Transplant; 2008 Jan; 41(2):173-82. PubMed ID: 18037944
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplantation in Glanzmann thrombasthenia complicated by platelet alloimmunization.
Wiegering V; Winkler B; Langhammer F; Wölfl M; Wirbelauer J; Sauer K; Kobsar A; Meyer T; Strauss A; Bakchoul T; Eyrich M; Schlegel PG
Klin Padiatr; 2011 May; 223(3):173-5. PubMed ID: 21567370
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic stem cell transplantation for Glanzmann thrombasthenia.
Ishaqi MK; El-Hayek M; Gassas A; Khanani M; Trad O; Baroudi M; Jamil A
Pediatr Blood Cancer; 2009 May; 52(5):682-3. PubMed ID: 19101997
[TBL] [Abstract][Full Text] [Related]
8. Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning.
Veys P; Rao K; Amrolia P
Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S45-7. PubMed ID: 15812530
[TBL] [Abstract][Full Text] [Related]
9. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L
Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651
[TBL] [Abstract][Full Text] [Related]
10. Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens.
Jiménez M; Ercilla G; Martínez C
Leukemia; 2007 Aug; 21(8):1628-37. PubMed ID: 17525730
[TBL] [Abstract][Full Text] [Related]
11. Favorable overall survival with fully myeloablative allogeneic stem cell transplantation for follicular lymphoma.
Kuruvilla J; Pond G; Tsang R; Gupta V; Lipton JH; Messner HA
Biol Blood Marrow Transplant; 2008 Jul; 14(7):775-82. PubMed ID: 18541196
[TBL] [Abstract][Full Text] [Related]
12. The evolution of hematopoietic SCT in myelodysplastic syndrome.
Kindwall-Keller T; Isola LM
Bone Marrow Transplant; 2009 Apr; 43(8):597-609. PubMed ID: 19252532
[TBL] [Abstract][Full Text] [Related]
13. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
[TBL] [Abstract][Full Text] [Related]
14. Successful father-to-son stem cell transplantation in a child with hemophagocytic lymphohistiocytosis using a reduced-intensity conditioning regimen.
Gonzalez-Llano O; Jaime-Pérez J; Cantu-Rodríguez O; Mancias-Guerra C; Gutierrez-Aguirre H; Herrera-Garza J; Gomez-Almaguer D
Eur J Haematol; 2006 Oct; 77(4):341-4. PubMed ID: 16856932
[TBL] [Abstract][Full Text] [Related]
15. Reduced-intensity conditioning in children: a reappraisal in 2008.
Yaniv I; Stein J;
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S18-22. PubMed ID: 18545237
[TBL] [Abstract][Full Text] [Related]
16. Use of allogeneic stem cell transplantation for moderate-severe Glanzmann thrombasthenia.
Walz A; Lenzen A; Curtis B; Canner J; Schneiderman J
Platelets; 2015; 26(7):702-4. PubMed ID: 25548835
[TBL] [Abstract][Full Text] [Related]
17. Evidence for megakaryocyte engraftment following reduced-intensity conditioning.
French DL; Fruchtman S; Mitchell WB; Coller BS; Peretz H
Exp Hematol; 2004 Sep; 32(9):877-80. PubMed ID: 15345290
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic blood stem cell transplantation following non-myeloablative conditioning for hypereosinophilic syndrome.
Juvonen E; Volin L; Koponen A; Ruutu T
Bone Marrow Transplant; 2002 Mar; 29(5):457-8. PubMed ID: 11919738
[TBL] [Abstract][Full Text] [Related]
19. Indication for allogeneic stem cell transplantation in Glanzmann's thrombasthenia.
Wiegering V; Sauer K; Winkler B; Eyrich M; Schlegel PG
Hamostaseologie; 2013; 33(4):305-12. PubMed ID: 23868573
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Michallet M; Le QH; Mohty M; Prébet T; Nicolini F; Boiron JM; Esperou H; Attal M; Milpied N; Lioure B; Bordigoni P; Yakoub-Agha I; Bourhis JH; Rio B; Deconinck E; Renaud M; Chir Z; Blaise D
Exp Hematol; 2008 May; 36(5):535-44. PubMed ID: 18346838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
